Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

François-Loïc Cosset

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Cell Line

Living Beings

Physiology

Procedures

Gene Therapy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Frecha Cecilia; Costa Caroline; Lévy Camille; Nègre Didier; Russell Stephen J; Maisner Andrea; Salles Gilles; Peng Kah-Whye; Cosset Francois-Loïc; Verhoeyen Els
Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors.
Benedicto Ignacio; Molina-Jiménez Francisca; Bartosch Birke; Cosset François-Loïc; Lavillette Dimitri; Prieto Jesús; Moreno-Otero Ricardo; Valenzuela-Fernández Agustín; Aldabe Rafael; López-Cabrera Manuel; Majano Pedro L
The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
Szécsi Judit; Gabriel Gülsah; Edfeldt Gabriella; Michelet Maud; Klenk Hans Dieter; Cosset François-Loïc
DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of François-Loïc Cosset (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Frecha Cecilia; Costa Caroline; Lévy Camille; Nègre Didier; Russell Stephen J; Maisner Andrea; Salles Gilles; Peng Kah-Whye; Cosset Francois-Loïc; Verhoeyen Els
Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors.
Blood 2009;114(15):3173-80.
2009: Benedicto Ignacio; Molina-Jiménez Francisca; Bartosch Birke; Cosset François-Loïc; Lavillette Dimitri; Prieto Jesús; Moreno-Otero Ricardo; Valenzuela-Fernández Agustín; Aldabe Rafael; López-Cabrera Manuel; Majano Pedro L
The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
Journal of virology 2009;83(16):8012-20.
2009: Szécsi Judit; Gabriel Gülsah; Edfeldt Gabriella; Michelet Maud; Klenk Hans Dieter; Cosset François-Loïc
DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus.
The Journal of infectious diseases 2009;200(2):181-90.
2009: Lourenço Sofia; Boni Sébastien; Furling Denis; Cosset François-Loïc; Cahour Annie
A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry site.
Journal of virological methods 2009;158(1-2):152-9.
2009: Desjardins Delphine; Huret Christophe; Dalba Charlotte; Kreppel Florian; Kochanek Stefan; Cosset François-Loïc; Tangy Frédéric; Klatzmann David; Bellier Bertrand
Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.
The journal of gene medicine 2009;11(4):313-25.
2009: Cosset François-Loic; Marianneau Philippe; Verney Geraldine; Gallais Fabrice; Tordo Noel; Pécheur Eve-Isabelle; ter Meulen Jan; Deubel Vincent; Bartosch Birke
Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles.
Journal of virology 2009;83(7):3228-37.
2009: Chhin Brigitte; Negre Didier; Merrot Olivier; Pham Jacqueline; Tourneur Yves; Ressnikoff Denis; Jaspers Martine; Jorissen Mark; Cosset François-Loïc; Bouvagnet Patrice
Ciliary beating recovery in deficient human airway epithelial cells after lentivirus ex vivo gene therapy.
PLoS genetics 2009;5(3):e1000422.
2009: Dreux Marlène; Dao Thi Viet Loan; Fresquet Judith; Guérin Maryse; Julia Zélie; Verney Géraldine; Durantel David; Zoulim Fabien; Lavillette Dimitri; Cosset François-Loïc; Bartosch Birke
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
PLoS pathogens 2009;5(2):e1000310.
2009: Dreux Marlène; Cosset François-Loïc
Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp).
Methods in molecular biology (Clifton, N.J.) 2009;510():427-38.
2009: Bartosch Birke; Cosset François-Loïc
Studying HCV cell entry with HCV pseudoparticles (HCVpp).
Methods in molecular biology (Clifton, N.J.) 2009;510():279-93.
2008: Frecha Cecilia; Costa Caroline; Nègre Didier; Gauthier Emmanuel; Russell Stephen J; Cosset François-Loïc; Verhoeyen Els
Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.
Blood 2008;112(13):4843-52.
2008: Haberstroh Anita; Schnober Eva K; Zeisel Mirjam B; Carolla Patric; Barth Heidi; Blum Hubert E; Cosset François-Loic; Koutsoudakis George; Bartenschlager Ralf; Union Ann; Depla Erik; Owsianka Ania; Patel Arvind H; Schuster Catherine; Stoll-Keller Françoise; Doffoël Michel; Dreux Marlène; Baumert Thomas F
Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
Gastroenterology 2008;135(5):1719-1728.e1.
2008: Fenouillet Emmanuel; Lavillette Dimitri; Loureiro Silvia; Krashias George; Maurin Guillemette; Cosset François-Loïc; Jones Ian M; Barbouche Rym
Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity.
The Journal of biological chemistry 2008;283(39):26340-8.
2008: Zeisel Mirjam B; Cosset François-Loïc; Baumert Thomas F
Host neutralizing responses and pathogenesis of hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2008;48(1):299-307.
2008: Keck Zhen-Yong; Olson Oakley; Gal-Tanamy Meital; Xia Jinming; Patel Arvind H; Dreux Marlène; Cosset Francois-Loïc; Lemon Stanley M; Foung Steven K H
A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope.
Journal of virology 2008;82(12):6067-72.
2008: Meertens Laurent; Bertaux Claire; Cukierman Lisa; Cormier Emmanuel; Lavillette Dimitri; Cosset François-Loïc; Dragic Tatjana
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
Journal of virology 2008;82(7):3555-60.
2008: Derdouch Sonia; Gay Wilfried; Nègre Didier; Prost Stéphane; Le Dantec Mikael; Delache Benoît; Auregan Gwenaelle; Andrieu Thibault; Leplat Jean-Jacques; Cosset François-Loïc; Le Grand Roger
Reconstitution of the myeloid and lymphoid compartments after the transplantation of autologous and genetically modified CD34+ bone marrow cells, following gamma irradiation in cynomolgus macaques.
Retrovirology 2008;5():50.
2007: Zeisel Mirjam B; Koutsoudakis George; Schnober Eva K; Haberstroh Anita; Blum Hubert E; Cosset François-Loïc; Wakita Takaji; Jaeck Daniel; Doffoel Michel; Royer Cathy; Soulier Eric; Schvoerer Evelyne; Schuster Catherine; Stoll-Keller Françoise; Bartenschlager Ralf; Pietschmann Thomas; Barth Heidi; Baumert Thomas F
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
Hepatology (Baltimore, Md.) 2007;46(6):1722-31.
2007: Dreux Marlène; Boson Bertrand; Ricard-Blum Sylvie; Molle Jennifer; Lavillette Dimitri; Bartosch Birke; Pécheur Eve-Isabelle; Cosset Francois-Loïc
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
The Journal of biological chemistry 2007;282(44):32357-69.
2007: Lavillette Dimitri; Pécheur Eve-Isabelle; Donot Peggy; Fresquet Judith; Molle Jennifer; Corbau Romuald; Dreux Marlène; Penin François; Cosset François-Loïc
Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
Journal of virology 2007;81(16):8752-65.
2007: Bouard David; Sandrin Virginie; Boson Bertrand; Nègre Didier; Thomas Gary; Granier Christelle; Cosset François-Loïc
An acidic cluster of the cytoplasmic tail of the RD114 virus glycoprotein controls assembly of retroviral envelopes.
Traffic (Copenhagen, Denmark) 2007;8(7):835-47.
2007: Gluzman Zoya; Koren Belly; Preis Meir; Cohen Tzafra; Tsaba Adili; Cosset Francois-Loic; Shofti Rona; Lewis Basil S; Virmani Renu; Flugelman Moshe Y
Endothelial cells are activated by angiopoeitin-1 gene transfer and produce coordinated sprouting in vitro and arteriogenesis in vivo.
Biochemical and biophysical research communications 2007;359(2):263-8.
2007: Pécheur Eve-Isabelle; Lavillette Dimitri; Alcaras Fanny; Molle Jennifer; Boriskin Yury S; Roberts Michael; Cosset François-Loïc; Polyak Stephen J
Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.
Biochemistry 2007;46(20):6050-9.
2007: Pestka Jan M; Zeisel Mirjam B; Bläser Edith; Schürmann Peter; Bartosch Birke; Cosset Francois-Loïc; Patel Arvind H; Meisel Helga; Baumert Jens; Viazov Sergei; Rispeter Kay; Blum Hubert E; Roggendorf Michael; Baumert Thomas F
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(14):6025-30.
2007: Chapel Cynthia; Garcia Céline; Bartosch Birke; Roingeard Philippe; Zitzmann Nicole; Cosset François-Loïc; Dubuisson Jean; Dwek Raymond A; Trépo Christian; Zoulim Fabien; Durantel David
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
The Journal of general virology 2007;88(Pt 4):1133-43.
2007: de Chassey Benoît; Mikaelian Ivan; Mathieu Anne-Laure; Bickle Marc; Olivier Delphine; Nègre Didier; Cosset François-Loïc; Rudkin Brian B; Colas Pierre
An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity.
Molecular & cellular proteomics : MCP 2007;6(3):451-9.
2006: Barth Heidi; Schnober Eva K; Zhang Fuming; Linhardt Robert J; Depla Erik; Boson Bertrand; Cosset Francois-Loic; Patel Arvind H; Blum Hubert E; Baumert Thomas F
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction.
Journal of virology 2006;80(21):10579-90.
2006: Szécsi Judit; Drury Rosybel; Josserand Véronique; Grange Marie-Pierre; Boson Bertrand; Hartl Irene; Schneider Richard; Buchholz Christian J; Coll Jean-Luc; Russell Stephen J; Cosset François-Loïc; Verhoeyen Els
Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(5):735-44.
2006: Heo Tae-Hwe; Lee Song-Mi; Bartosch Birke; Cosset François-Loïc; Kang Chang-Yuil
Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
Virus research 2006;121(1):58-64.
2006: Voisset Cécile; Op de Beeck Anne; Horellou Pauline; Dreux Marlène; Gustot Thierry; Duverlie Gilles; Cosset François-Loic; Vu-Dac Ngoc; Dubuisson Jean
High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.
The Journal of general virology 2006;87(Pt 9):2577-81.
2006: Koren Belly; Weisz Anat; Fischer Lukas; Gluzman Zoya; Preis Meir; Avramovitch Naomi; Cohen Tzafra; Cosset Francois-Loic; Lewis Basil S; Flugelman Moshe Y
Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
Cardiovascular revascularization medicine : including molecular interventions 2006;7(3):173-8.
2006: Dreux Marlène; Pietschmann Thomas; Granier Christelle; Voisset Cécile; Ricard-Blum Sylvie; Mangeot Philippe-Emmanuel; Keck Zhenyong; Foung Steven; Vu-Dac Ngoc; Dubuisson Jean; Bartenschlager Ralf; Lavillette Dimitri; Cosset Francois-Loïc
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
The Journal of biological chemistry 2006;281(27):18285-95.
2006: Swainson Louise; Verhoeyen Els; Cosset François-Loïc; Taylor Naomi
IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(11):6702-8.
2006: Pietschmann Thomas; Kaul Artur; Koutsoudakis George; Shavinskaya Anna; Kallis Stephanie; Steinmann Eike; Abid Karim; Negro Francesco; Dreux Marlene; Cosset Francois-Loic; Bartenschlager Ralf
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(19):7408-13.
2006: Dreux Marlène; Cosset Francois-Loïc
HCV and lipoproteins: is oxLDL an Achilles' heel of the Trojan horse?
Hepatology (Baltimore, Md.) 2006;43(5):903-5.
2006: Bartosch Birke; Cosset François-Loïc
Cell entry of hepatitis C virus.
Virology 2006;348(1):1-12.
2006: Lavillette Dimitri; Barbouche Rym; Yao Yongxiu; Boson Bertrand; Cosset François-Loïc; Jones Ian M; Fenouillet Emmanuel
Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelope.
The Journal of biological chemistry 2006;281(14):9200-4.
2006: Bellier Bertrand; Dalba Charlotte; Clerc Béatrice; Desjardins Delphine; Drury Rosybel; Cosset François-Loïc; Collins Mary; Klatzmann David
DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.
Vaccine 2006;24(14):2643-55.
2006: Fluckiger Anne-Catherine; Marcy Guillaume; Marchand Mélanie; Négre Didier; Cosset François-Loïc; Mitalipov Shoukhrat; Wolf Don; Savatier Pierre; Dehay Colette
Cell cycle features of primate embryonic stem cells.
Stem cells (Dayton, Ohio) 2006;24(3):547-56.
2006: Broer Rene; Boson Bertrand; Spaan Willy; Cosset François-Loïc; Corver Jeroen
Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.
Journal of virology 2006;80(3):1302-10.
2006: Lavillette Dimitri; Bartosch Birke; Nourrisson Delphine; Verney Géraldine; Cosset François-Loïc; Penin François; Pécheur Eve-Isabelle
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes.
The Journal of biological chemistry 2006;281(7):3909-17.
2006: Sandrin Virginie; Cosset François-Loïc
Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein.
The Journal of biological chemistry 2006;281(1):528-42.
2006: Szécsi Judit; Boson Bertrand; Johnsson Per; Dupeyrot-Lacas Pia; Matrosovich Mikhail; Klenk Hans-Dieter; Klatzmann David; Volchkov Viktor; Cosset François-Loïc
Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses.
Virology journal 2006;3():70.
2005: Youn Jin-Won; Park Su-Hyung; Lavillette Dimitri; Cosset Francois-Loic; Yang Se-Hwan; Lee Chang Geun; Jin Hyun-Tak; Kim Chang-Min; Shata Mohamed Tarek M; Lee Dong-Hun; Pfahler Wolfram; Prince Alfred M; Sung Young Chul
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.
Hepatology (Baltimore, Md.) 2005;42(6):1429-36.
2005: Callens Nathalie; Ciczora Yann; Bartosch Birke; Vu-Dac Ngoc; Cosset François-Loïc; Pawlotsky Jean-Michel; Penin François; Dubuisson Jean
Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.
Journal of virology 2005;79(24):15331-41.
2005: Sandrin Virginie; Boulanger Pierre; Penin Francois; Granier Christelle; Cosset François-Loïc; Bartosch Birke
Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins.
The Journal of general virology 2005;86(Pt 12):3189-99.
2005: Schofield Darren J; Bartosch Birke; Shimizu Yohko K; Allander Tobias; Alter Harvey J; Emerson Suzanne U; Cosset François-Loïc; Purcell Robert H
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
Hepatology (Baltimore, Md.) 2005;42(5):1055-62.
2005: Keck Zhen-Yong; Li Ta-Kai; Xia Jinming; Bartosch Birke; Cosset François-Loïc; Dubuisson Jean; Foung Steven K H
Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2.
Journal of virology 2005;79(21):13199-208.
2005: Verhoeyen Els; Wiznerowicz Maciej; Olivier Delphine; Izac Brigitte; Trono Didier; Dubart-Kupperschmitt Anne; Cosset François-Loïc
Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells.
Blood 2005;106(10):3386-95.
2005: Ciczora Yann; Callens Nathalie; Montpellier Claire; Bartosch Birke; Cosset François-Loïc; Op de Beeck Anne; Dubuisson Jean
Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer.
The Journal of general virology 2005;86(Pt 10):2793-8.
2005: Owsianka Ania; Tarr Alexander W; Juttla Vicky S; Lavillette Dimitri; Bartosch Birke; Cosset François-Loïc; Ball Jonathan K; Patel Arvind H
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.
Journal of virology 2005;79(17):11095-104.
2005: Dupuy Franck P; Mouly Enguerran; Mesel-Lemoine Mariana; Morel Céline; Abriol Julien; Cherai Mustapha; Baillou Claude; Nègre Didier; Cosset François-Loïc; Klatzmann David; Lemoine François M
Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
The journal of gene medicine 2005;7(9):1158-71.
2005: Goffard Anne; Callens Nathalie; Bartosch Birke; Wychowski Czeslaw; Cosset François-Loïc; Montpellier Claire; Dubuisson Jean
Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.
Journal of virology 2005;79(13):8400-9.
2005: Bartosch Birke; Verney Géraldine; Dreux Marlène; Donot Peggy; Morice Yoann; Penin François; Pawlotsky Jean-Michel; Lavillette Dimitri; Cosset Francois-Loïc
An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.
Journal of virology 2005;79(13):8217-29.
2005: Lavillette Dimitri; Morice Yoann; Germanidis Georgios; Donot Peggy; Soulier Alexandre; Pagkalos Emanuil; Sakellariou Georgios; Intrator Liliane; Bartosch Birke; Pawlotsky Jean-Michel; Cosset François-Loïc
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
Journal of virology 2005;79(10):6023-34.
2005: Cheynet V; Ruggieri A; Oriol G; Blond J-L; Boson B; Vachot L; Verrier B; Cosset F-L; Mallet F
Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope.
Journal of virology 2005;79(9):5585-93.
2005: Meunier Jean-Christophe; Engle Ronald E; Faulk Kristina; Zhao Ming; Bartosch Birke; Alter Harvey; Emerson Suzanne U; Cosset Francois-Loic; Purcell Robert H; Bukh Jens
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(12):4560-5.
2005: Trajcevski Stéphane; Solly Sounkary K; Frisén Charlotte; Trenado Aurélie; Cosset François-Loïc; Klatzmann David
Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
The journal of gene medicine 2005;7(3):276-87.
2005: Lavillette Dimitri; Tarr Alexander W; Voisset Cécile; Donot Peggy; Bartosch Birke; Bain Christine; Patel Arvind H; Dubuisson Jean; Ball Jonathan K; Cosset François-Loïc
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
Hepatology (Baltimore, Md.) 2005;41(2):265-74.
2004: Bartosch Birke; Cosset Francois-Loic
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
Current gene therapy 2004;4(4):427-43.
2004: Jevremovic Dragan; Gulati Rajiv; Hennig Ivo; Diaz Rosa Maria; Cole Caroline; Kleppe Laurel; Cosset Francois Loic; Simari Robert D; Vile Richard G
Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors.
American journal of physiology. Heart and circulatory physiology 2004;287(2):H494-500.
2004: Sandrin Virginie; Muriaux Delphine; Darlix Jean-Luc; Cosset François-Loïc
Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Journal of virology 2004;78(13):7153-64.
2004: Lozach Pierre-Yves; Amara Ali; Bartosch Birke; Virelizier Jean-Louis; Arenzana-Seisdedos Fernando; Cosset François-Loïc; Altmeyer Ralf
C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.
The Journal of biological chemistry 2004;279(31):32035-45.
2004: Yu Mei-ying W; Bartosch Birke; Zhang Pei; Guo Zheng-ping; Renzi Paula M; Shen Li-Ming; Granier Christelle; Feinstone Stephen M; Cosset François-Loïc; Purcell Robert H
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(20):7705-10.
2004: Strang B L; Ikeda Y; Cosset F-L; Collins M K L; Takeuchi Y
Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells.
Gene therapy 2004;11(7):591-8.
2004: Op De Beeck Anne; Voisset Cécile; Bartosch Birke; Ciczora Yann; Cocquerel Laurence; Keck Zhenyong; Foung Steven; Cosset François-Loïc; Dubuisson Jean
Characterization of functional hepatitis C virus envelope glycoproteins.
Journal of virology 2004;78(6):2994-3002.
2004: Verhoeyen Els; Cosset François-Loïc
Surface-engineering of lentiviral vectors.
The journal of gene medicine 2004;6 Suppl 1():S83-94.
2004: Psarras Stelios; Karagianni Niki; Kellendonk Christoph; Tronche François; Cosset François-Loic; Stocking Carol; Schirrmacher Volker; Boehmer Hv Harald von; Khazaie Khashayarsha
Gene transfer and genetic modification of embryonic stem cells by Cre- and Cre-PR-expressing MESV-based retroviral vectors.
The journal of gene medicine 2004;6(1):32-42.
2004: Blaise Sandra; Ruggieri Alessia; Dewannieux Marie; Cosset François-Loic; Heidmann Thierry
Identification of an envelope protein from the FRD family of human endogenous retroviruses (HERV-FRD) conferring infectivity and functional conservation among simians.
Journal of virology 2004;78(2):1050-4.
2004: Mangeot Philippe-Emmanuel; Cosset François-Loïc; Colas Pierre; Mikaelian Ivan
A universal transgene silencing method based on RNA interference.
Nucleic acids research 2004;32(12):e102.
2003: Bartosch Birke; Bukh Jens; Meunier Jean-Christophe; Granier Christelle; Engle Ronald E; Blackwelder William C; Emerson Suzanne U; Cosset François-Loïc; Purcell Robert H
In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):14199-204.
2003: Bartosch Birke; Vitelli Alessandra; Granier Christelle; Goujon Caroline; Dubuisson Jean; Pascale Simona; Scarselli Elisa; Cortese Riccardo; Nicosia Alfredo; Cosset François-Loïc
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
The Journal of biological chemistry 2003;278(43):41624-30.
2003: Crittenden Marka; Gough Michael; Chester John; Kottke Tim; Thompson Jill; Ruchatz Anja; Clackson Tim; Cosset Francois Luic; Chong Heung; Diaz Rosa Maria; Harrington Kevin; Alvarez Vallina Luis; Vile Richard
Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
Cancer research 2003;63(12):3173-80.
2003: Ikeda Yasuhiro; Takeuchi Yasuhiro; Martin Francisco; Cosset Francois-Loic; Mitrophanous Kyriacos; Collins Mary
Continuous high-titer HIV-1 vector production.
Nature biotechnology 2003;21(5):569-72.
2003: Bartosch Birke; Dubuisson Jean; Cosset François-Loïc
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
The Journal of experimental medicine 2003;197(5):633-42.
2003: Verhoeyen Els; Dardalhon Valerie; Ducrey-Rundquist Odile; Trono Didier; Taylor Naomi; Cosset François-Loïc
IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes.
Blood 2003;101(6):2167-74.
2003: Martin Francisco; Chowdhury Simon; Neil Stuart J; Chester Kerry A; Cosset Francois-Loic; Collins Mary K
Targeted retroviral infection of tumor cells by receptor cooperation.
Journal of virology 2003;77(4):2753-6.
2003: Sandrin V; Russell S J; Cosset F L
Targeting retroviral and lentiviral vectors.
Current topics in microbiology and immunology 2003;281():137-78.
2003: Ruggieri Alessia; Nègre Didier; Cosset François-Loïc
SIV Vectors.
Methods in molecular biology (Clifton, N.J.) 2003;229():233-49.
2002: Nègre Didier; Cosset François-Loïc
Vectors derived from simian immunodeficiency virus (SIV).
Biochimie 2002;84(11):1161-71.
2002: Duisit Ghislaine; Conrath Hervé; Saleun Sylvie; Folliot Sebastien; Provost Nathalie; Cosset François-Loïc; Sandrin Virginie; Moullier Philippe; Rolling Fabienne
Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(4):446-54.
2002: Lavillette Dimitri; Ruggieri Alessia; Boson Bertrand; Maurice Marielle; Cosset François-Loïc
Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
Journal of virology 2002;76(19):9673-85.
2002: Sandrin Virginie; Boson Bertrand; Salmon Patrick; Gay Wilfried; Nègre Didier; Le Grand Roger; Trono Didier; Cosset François-Loïc
Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.
Blood 2002;100(3):823-32.
2002: Roberts Michael L; Wells Dominic J; Graham Ian R; Fabb Stewart A; Hill Vanessa J; Duisit Ghislaine; Yuasa Katsutoshi; Takeda Shin'ichi; Cosset François-Loïc; Dickson George
Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
Human molecular genetics 2002;11(15):1719-30.
2002: Lavillette Dimitri; Marin Mariana; Ruggieri Alessia; Mallet François; Cosset François-Loïc; Kabat David
The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors.
Journal of virology 2002;76(13):6442-52.
2002: Maurice Marielle; Verhoeyen Els; Salmon Patrick; Trono Didier; Russell Stephen J; Cosset François-Loïc
Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide.
Blood 2002;99(7):2342-50.
2002: Chester John; Ruchatz Anja; Gough Michael; Crittenden Marka; Chong Heung; Cosset François-Loïc; Diaz Rosa Maria; Harrington Kevin; Alvarez-Vallina Luis; Vile Richard
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells.
Nature biotechnology 2002;20(3):256-63.
2002: Mangeot Philippe-Emmanuel; Duperrier Karine; Nègre Didier; Boson Bertrand; Rigal Dominique; Cosset François-Loïc; Darlix Jean-Luc
High levels of transduction of human dendritic cells with optimized SIV vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(3):283-90.
2002: Nègre D; Duisit G; Mangeot P E; Moullier P; Darlix J L; Cosset F L
Lentiviral vectors derived from simian immunodeficiency virus.
Current topics in microbiology and immunology 2002;261():53-74.
2001: Roberts M L; Athanasopoulos T; Pohlschmidt M; Duisit G; Cosset F L; Dickson G
Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates.
Gene therapy 2001;8(20):1580-6.
2001: Lavillette D; Russell S J; Cosset F L
Retargeting gene delivery using surface-engineered retroviral vector particles.
Current opinion in biotechnology 2001;12(5):461-6.
2001: Lavillette D; Boson B; Russell S J; Cosset F L
Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
Journal of virology 2001;75(8):3685-95.
2000: Zhao-Emonet J C; Marodon G; Pioche-Durieu C; Cosset F L; Klatzmann D
T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
The journal of gene medicine 2000;2(6):416-25.
2000: Nègre D; Mangeot P E; Duisit G; Blanchard S; Vidalain P O; Leissner P; Winter A J; Rabourdin-Combe C; Mehtali M; Moullier P; Darlix J L; Cosset F L
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.
Gene therapy 2000;7(19):1613-23.
2000: Mangeot P E; Nègre D; Dubois B; Winter A J; Leissner P; Mehtali M; Kaiserlian D; Cosset F L; Darlix J L
Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells.
Journal of virology 2000;74(18):8307-15.
2000: Kim F J; Seiliez I; Denesvre C; Lavillette D; Cosset F L; Sitbon M
Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus.
The Journal of biological chemistry 2000;275(31):23417-20.
2000: Fielding A K; Chapel-Fernandes S; Chadwick M P; Bullough F J; Cosset F L; Russell S J
A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
Human gene therapy 2000;11(6):817-26.
2000: Blond J L; Lavillette D; Cheynet V; Bouton O; Oriol G; Chapel-Fernandes S; Mandrand B; Mallet F; Cosset F L
An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.
Journal of virology 2000;74(7):3321-9.
2000: Bateman A; Bullough F; Murphy S; Emiliusen L; Lavillette D; Cosset F L; Cattaneo R; Russell S J; Vile R G
Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.
Cancer research 2000;60(6):1492-7.
2000: Hatziioannou T; Russell S J; Cosset F L
Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
Virology 2000;267(1):49-57.
2000: Lavillette D; Ruggieri A; Russell S J; Cosset F L
Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.
Journal of virology 2000;74(1):295-304.
1999: Russell S J; Cosset F L
Modifying the host range properties of retroviral vectors.
The journal of gene medicine 1999;1(5):300-11.
1999: Peng K W; Vile R; Cosset F L; Russell S
Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors.
Gene therapy 1999;6(9):1552-7.
1999: Martin F; Neil S; Kupsch J; Maurice M; Cosset F; Collins M
Retrovirus targeting by tropism restriction to melanoma cells.
Journal of virology 1999;73(8):6923-9.
1999: Maurice M; Mazur S; Bullough F J; Salvetti A; Collins M K; Russell S J; Cosset F L
Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins.
Blood 1999;94(2):401-10.
1999: Hatziioannou T; Delahaye E; Martin F; Russell S J; Cosset F L
Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.
Human gene therapy 1999;10(9):1533-44.
1999: Duisit G; Salvetti A; Moullier P; Cosset F L
Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines.
Human gene therapy 1999;10(2):189-200.
1999: Movassagh M; Baillou C; Cosset F L; Klatzmann D; Guigon M; Lemoine F M
High level of retrovirus-mediated gene transfer into dendritic cells derived from cord blood and mobilized peripheral blood CD34+ cells.
Human gene therapy 1999;10(2):175-87.
1999: Chadwick M P; Morling F J; Cosset F L; Russell S J
Modification of retroviral tropism by display of IGF-I.
Journal of molecular biology 1999;285(2):485-94.
1998: Lavillette D; Maurice M; Roche C; Russell S J; Sitbon M; Cosset F L
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.
Journal of virology 1998;72(12):9955-65.
1998: Marandin A; Dubart A; Pflumio F; Cosset F L; Cordette V; Chapel-Fernandes S; Coulombel L; Vainchenker W; Louache F
Retrovirus-mediated gene transfer into human CD34+38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo.
Human gene therapy 1998;9(10):1497-511.
1998: Hatziioannou T; Valsesia-Wittmann S; Russell S J; Cosset F L
Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses.
Journal of virology 1998;72(6):5313-7.
1998: Martin F; Kupsch J; Takeuchi Y; Russell S; Cosset F L; Collins M
Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.
Human gene therapy 1998;9(5):737-46.
1998: Fielding A K; Maurice M; Morling F J; Cosset F L; Russell S J
Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells.
Blood 1998;91(5):1802-9.
1997: Savard N; Cosset F L; Epstein A L
Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors.
Journal of virology 1997;71(5):4111-7.
1997: Valsesia-Wittmann S; Morling F J; Hatziioannou T; Russell S J; Cosset F L
Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.
The EMBO journal 1997;16(6):1214-23.
1996: Cosset F L; Russell S J
Targeting retrovirus entry.
Gene therapy 1996;3(11):946-56.
1996: Ager S; Nilson B H; Morling F J; Peng K W; Cosset F L; Russell S J
Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity.
Human gene therapy 1996;7(17):2157-64.
1996: Girod A; Drynda A; Cosset F L; Verdier G; Ronfort C
Homologous and nonhomologous retroviral recombinations are both involved in the transfer by infectious particles of defective avian leukosis virus-derived transcomplementing genomes.
Journal of virology 1996;70(8):5651-7.
1996: Denesvre C; Carrington C; Corbin A; Takeuchi Y; Cosset F L; Schulz T; Sitbon M; Sonigo P
TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.
Journal of virology 1996;70(7):4380-6.
1996: Jouan-Dufournel I; Cosset F L; Contamine D; Verdier G; Biémont C
Transposable elements behavior following viral genomic stress in Drosophila melanogaster inbred line.
Journal of molecular evolution 1996;43(1):19-27.
1996: Nilson B H; Morling F J; Cosset F L; Russell S J
Targeting of retroviral vectors through protease-substrate interactions.
Gene therapy 1996;3(4):280-6.
1996: Valsesia-Wittmann S; Morling F J; Nilson B H; Takeuchi Y; Russell S J; Cosset F L
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
Journal of virology 1996;70(3):2059-64.
1995: Thoraval P; Afanassieff M; Cosset F L; Lasserre F; Verdier G; Coudert F; Dambrine G
Germline transmission of exogenous genes in chickens using helper-free ecotropic avian leukosis virus-based vectors.
Transgenic research 1995;4(6):369-77.
1995: Cosset F L; Morling F J; Takeuchi Y; Weiss R A; Collins M K; Russell S J
Retroviral retargeting by envelopes expressing an N-terminal binding domain.
Journal of virology 1995;69(10):6314-22.
1995: Girod A; Cosset F L; Verdier G; Ronfort C
Analysis of ALV-based packaging cell lines for production of contaminant defective viruses.
Virology 1995;209(2):671-5.
1995: Ronfort C; Girod A; Cosset F L; Legras C; Nigon V M; Chebloune Y; Verdier G
Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line.
Virology 1995;207(1):271-5.
1995: Ronfort C; Chebloune Y; Cosset F L; Faure C; Nigon V M; Verdier G
Structure and expression of endogenous retroviral sequences in the permanent LMH chicken cell line.
Poultry science 1995;74(1):127-35.
1994: Valsesia-Wittmann S; Drynda A; Deléage G; Aumailley M; Heard J M; Danos O; Verdier G; Cosset F L
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.
Journal of virology 1994;68(7):4609-19.
1993: Jaffredo T; Molina R M; al Moustafa A E; Gautier R; Cosset F L; Verdier G; Dieterlen-Lièvre F
Patterns of integration and expression of retroviral, non-replicative vectors in avian embryos: embryo developmental stage and virus subgroup envelope modulate tissue-tropism.
Cell adhesion and communication 1993;1(2):119-32.
1993: Bagnis C; Cosset F L; Samarut J; Moscovici G; Moscovici C
Leukemogenicity of v-myb-transformed monoblasts cells can be modulated by normal bone marrow environment.
Oncogene 1993;8(3):737-43.
1993: Cosset F L; Girod A; Flamant F; Drynda A; Ronfort C; Valsesia S; Molina R M; Faure C; Nigon V M; Verdier G
Use of helper cells with two host ranges to generate high-titer retroviral vectors.
Virology 1993;193(1):385-95.
1993: Flamant F; Aubert D; Legrand C; Cosset F L; Samarut J
Importance of 3' non-coding sequences for efficient retrovirus-mediated gene transfer in avian cells revealed by self-inactivating vectors.
The Journal of general virology 1993;74 ( Pt 1)():39-46.
1992: Cosset F L; Ronfort C; Molina R M; Flamant F; Drynda A; Benchaibi M; Valsesia S; Nigon V M; Verdier G
Packaging cells for avian leukosis virus-based vectors with various host ranges.
Journal of virology 1992;66(9):5671-6.
1992: Thomas J L; Afanassieff M; Cosset F L; Molina R M; Ronfort C; Drynda A; Legras C; Chebloune Y; Nigon V M; Verdier G
In situ expression of helper-free avian leukosis virus (ALV)-based retrovirus vectors in early chick embryos.
The International journal of developmental biology 1992;36(2):215-27.
1991: Cosset F L; Bouquet J F; Drynda A; Chebloune Y; Rey-Senelonge A; Kohen G; Nigon V M; Desmettre P; Verdier G
Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-neuraminidase glycoprotein.
Virology 1991;185(2):862-6.
1991: Chebloune Y; Rulka J; Cosset F L; Valsesia S; Ronfort C; Legras C; Drynda A; Kuzmak J; Nigon V M; Verdier G
Immune response and resistance to Rous sarcoma virus challenge of chickens immunized with cell-associated glycoproteins provided with a recombinant avian leukosis virus.
Journal of virology 1991;65(10):5374-80.
1991: Cosset F L; Legras C; Thomas J L; Molina R M; Chebloune Y; Faure C; Nigon V M; Verdier G
Improvement of avian leukosis virus (ALV)-based retrovirus vectors by using different cis-acting sequences from ALVs.
Journal of virology 1991;65(6):3388-94.
1990: Cosset F L; Legras C; Chebloune Y; Savatier P; Thoraval P; Thomas J L; Samarut J; Nigon V M; Verdier G
A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes.
Journal of virology 1990;64(3):1070-8.
1989: Savatier P; Bagnis C; Thoraval P; Poncet D; Belakebi M; Mallet F; Legras C; Cosset F L; Thomas J L; Chebloune Y
Generation of a helper cell line for packaging avian leukosis virus-based vectors.
Journal of virology 1989;63(2):513-22.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

François-Loïc Cosset

Research Profile (preview)

Chemicals & Drugs

Anatomy

Living Beings

Concepts & Ideas

Devices

Genes & Molecular Sequences

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of François-Loïc Cosset (preview)

All Publications